A phase I, placebo controlled, dose escalation safety and pharmacokinetic study of (Z)-Endoxifen in healthy female volunteers

Trial Profile

A phase I, placebo controlled, dose escalation safety and pharmacokinetic study of (Z)-Endoxifen in healthy female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Oct 2017

At a glance

  • Drugs Endoxifen (Primary) ; Endoxifen (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Sponsors Atossa Genetics
  • Most Recent Events

    • 25 Oct 2017 According to a Atossa Genetics media release, company will host a conference call to discuss preliminary results from oral Endoxifen arm on 25 Oct 2017.
    • 25 Sep 2017 Preliminary results published in an Atossa Genetics Media Release
    • 18 Sep 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top